Triazolyl tryptoline derivatives as β-secretase inhibitors

被引:21
作者
Jiaranaikulwanitch, Jutamas [1 ]
Boonyarat, Chantana [2 ]
Fokin, Valery V. [3 ]
Vajragupta, Opa [1 ]
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharmaceut Chem, Bangkok 10400, Thailand
[2] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen 40002, Thailand
[3] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
关键词
BACE1; inhibitor; JJCA-140; Tryptoline; Docking; Binding mode; Enzyme assay; Cathepsin-D; ALZHEIMERS-DISEASE; EFFICIENCY INDEXES; LIGAND EFFICIENCY; DRUG DISCOVERY; DESIGN; BACE-1;
D O I
10.1016/j.bmcl.2010.09.043
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tryptoline, a core structure of ochrolifuanine E, which is a hit compound from virtual screening of the Thai herbal database against BACE1 was used as a scaffold for the design of BACE1 inhibitors. The tryptoline was linked with different side chains by 1,2,3-triazole ring readily synthesized by catalytic azide-alkyne cycloaddition reactions. Twenty two triazolyl tryptoline derivatives were synthesized and screened for the inhibitory action against BACE1. JJCA-140 was the most potent inhibitor (IC(50) = 1.49 mu M) and was 100 times more selective for BACE1 than for Cat-D. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6572 / 6576
页数:5
相关论文
共 26 条
[1]   Ligand efficiency indices as guideposts for drug discovery [J].
Abad-Zapatero, C ;
Metz, JT .
DRUG DISCOVERY TODAY, 2005, 10 (07) :464-469
[2]   Strategies for disease modification in Alzheimer's disease [J].
Citron, M .
NATURE REVIEWS NEUROSCIENCE, 2004, 5 (09) :677-685
[3]   Acylguanidines as small-molecule β-secretase inhibitors [J].
Cole, Derek C. ;
Manas, Eric S. ;
Stock, Joseph R. ;
Condon, Jeffrey S. ;
Jennings, Lee D. ;
Aulabaugh, Ann ;
Chopra, Rajiv ;
Cowling, Rebecca ;
Ellingboe, John W. ;
Fan, Kristi Y. ;
Harrison, Boyd L. ;
Hu, Yun ;
Jacobsen, Steve ;
Jin, Guixan ;
Lin, Laura ;
Lovering, Frank E. ;
Malamas, Michael S. ;
Stahl, Mark L. ;
Strand, James ;
Sukhdeo, Mohani N. ;
Svenson, Kristine ;
Turner, M. James ;
Wagner, Erik ;
Wu, Junjun ;
Zhou, Ping ;
Bard, Jonathan .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) :6158-6161
[4]   Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of β-secretase [J].
Congreve, Miles ;
Aharony, David ;
Albert, Jeffrey ;
Callaghan, Owen ;
Campbell, James ;
Carr, Robin A. E. ;
Chessari, Gianni ;
Cowan, Suzanna ;
Edwards, Philip D. ;
Frederickson, Martyn ;
McMenamin, Rachel ;
Murray, Christopher W. ;
Patel, Sahil ;
Wallis, Nicola .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) :1124-1132
[5]   The role of amyloid β peptide 42 in Alzheimer's disease [J].
Findeis, Mark A. .
PHARMACOLOGY & THERAPEUTICS, 2007, 116 (02) :266-286
[6]   Design, synthesis, and X-ray structure of potent memapsin 2 (β-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands [J].
Ghosh, Arun K. ;
Kumaragurubaran, Nagaswamy ;
Hong, Lin ;
Kulkarni, Sarang S. ;
Xu, Xiaoming ;
Chang, Wanpin ;
Weerasena, Vajira ;
Turner, Robert ;
Koelsch, Gerald ;
Bilcer, Geoffrey ;
Tang, Jordan .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) :2399-2407
[7]   Fragment-Based Discovery of BACE1 Inhibitors Using Functional Assays [J].
Godemann, Robert ;
Madden, James ;
Kraemer, Joachim ;
Smith, Myron ;
Fritz, Ulrike ;
Hesterkamp, Thomas ;
Barker, John ;
Hoeppner, Sabine ;
Hallett, David ;
Cesura, Andrea ;
Ebneth, Andreas ;
Kemp, John .
BIOCHEMISTRY, 2009, 48 (45) :10743-10751
[8]   Protein modelling for all [J].
Guex, N ;
Diemand, A ;
Peitsch, MC .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (09) :364-367
[9]   Inflammatory processes in Alzheimer's disease [J].
Heneka, Michael T. ;
O'Banion, M. Kerry .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 184 (1-2) :69-91
[10]   Structure-based calculation of drug efficiency indices [J].
Hetenyi, Csaba ;
Maran, Uko ;
Garcia-Sosa, Alfonso T. ;
Karelson, Mati .
BIOINFORMATICS, 2007, 23 (20) :2678-2685